Advertisement · 728 × 90
#
Hashtag
#GDRX
Advertisement · 728 × 90
🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVGO, #PYPL, #GME, #GDRX, #SERV

#OptionFlow #OptionsTrading #Trading

0 0 0 0
Preview
GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill GoodRx (Nasdaq: GDRX) announced the Wegovy® pill (oral semaglutide) is available at a $149/month cash price for the two lowest doses (1.5mg and 4mg) at more than 70,000 pharmacies nationwide through GoodRx, with telemedicine access via GoodRx for Weight Loss to assess eligibility and prescribe when appropriate. The promotional $149 price for 4mg applies through April 15, 2026, then $199/month will apply; 9mg and 25mg doses are $299/month. GoodRx reports nearly 30 million annual consumers and says it has helped save over $85 billion since 2011.

#GDRX GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

www.stocktitan.net/news/GDRX/good-rx-now-of...

0 0 0 0
Preview
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® GoodRx (Nasdaq: GDRX) launched GoodRx for Weight Loss, a telemedicine subscription for FDA-approved GLP-1 weight-loss care and announced an introductory cash price for Ozempic and Wegovy pens. The subscription is $39/month introductory through January 2026, rising to $119/month on February 1, 2026. GoodRx offers an introductory price of $199/month for the first two fills of the two lowest doses (0.25 mg, 0.5 mg) for Ozempic and Wegovy, moving to $349/month thereafter; self-pay Ozempic 2.0 mg remains $499. Offer valid through March 31, 2026. GoodRx cites nearly 30 million users and $85 billion saved since 2011.

#GDRX GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

www.stocktitan.net/news/GDRX/good-rx-launch...

0 0 0 0
Preview
GoodRx Reports Third Quarter 2025 Results GoodRx Holdings, Inc., the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025.. Revenue of $196.0 million Net income of $1.1 million; Net income margin of 0.6% Adjusted Net Income 1 of $28.8 million; Adjusted Net Income Margin 1 of 14.7% Adjusted EBITDA 1 of $66.3 million; Adjusted EBITDA Margin 1 of...

#GDRX GoodRx Reports Third Quarter 2025 Results

www.stocktitan.net/news/GDRX/good-rx-report...

0 0 0 0
Preview
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment GoodRx (Nasdaq: GDRX) launched GoodRx for Hair Loss on October 15, 2025, a subscription service for men that bundles a virtual consultation, clinically proven prescription medications, and home delivery.The service offers prescriptions for oral finasteride or oral minoxidil, guarantees discreet delivery with no fee, and advertises pricing starting at $16/month (final price varies by medication and delivery cadence). GoodRx positions the product as a simpler, lower-cost alternative to multi‑step kits and highlights its platform scale: nearly 30 million consumers and over $85 billion saved since 2011.

#GDRX GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment

www.stocktitan.net/news/GDRX/good-rx-launch...

0 0 0 0
Most Searched, Thursday October 9, 2025 – Crystal Equity Research

Most searched small-cap stocks, Thu Oct 9th - #RCAT #SERV #BAOS #LAES #NVTS #DVLT #USAR #WRD #ALIT #SRPT #TMQ #RAMP #NAOV #LUNR #FCEL #CRML #CERS #BTCS #GDRX #ATCH - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
Most Searched, Wednesday October 1, 2025 – Crystal Equity Research

Most searched small-cap stocks, Wed Oct 1st - #AKAN #NVTS #ONDS #PTON #RIG #RXRX #CLOV #HIVE #HCTI #GDRX #RZLBV #DNN #PLUG #WRD #TLRY #EXK #LUNR #LAC #HUT - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #ALK 7.5x
2. #PGY 4.0x
3. #GDRX 3.4x
4. #PYPL 2.6x
5. #GFS 2.5x

#OptionFlow #OptionsTrading #Trading

0 0 0 0
🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#ALK, #PGY, #GDRX, #PYPL, #DOW

#OptionFlow #OptionsTrading #Trading

0 0 0 0
Preview
Healthcare Giant GoodRx Unveils 'Savings Wrangler' Campaign After Helping Americans Save $85B on Prescriptions GoodRx launches Western-themed campaign featuring cowgirl hero to tackle prescription costs. Campaign includes Times Square takeover, TV spots, and digital rollout. Platform has saved users over $85B since 2011.

#GDRX GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing

www.stocktitan.net/news/GDRX/good-rx-saddle...

0 0 0 0
Post image

Which stock would you buy?
📊 #NVO vs #GDRX 📉📈 💰🫣

#eloyhernandez

0 0 0 0
🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CVX, #GDRX, #VIK, #IQ, #DKNG

#OptionFlow #OptionsTrading #Trading

1 0 0 0
🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#SEDG, #GDRX, #CRCL, #KYIV, #PHAT

#OptionFlow #OptionsTrading #Trading

0 0 0 0
🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #MDT 14.4x
2. #CVX 11.1x
3. #GDRX 8.4x
4. #VIK 5.6x
5. #MO 4.7x

#OptionFlow #OptionsTrading #Trading

0 0 0 0
🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #UNH 60% OTM
2. #SEDG 58% OTM
3. #RIVN 52% OTM
4. #OPEN 41% OTM
5. #GDRX 39% OTM

#OptionFlow #OptionsTrading #Trading

0 0 0 0
Most Searched, Monday August 18, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Aug 18th - #BSGM #DAWN #SNGX #OPEN #WULF #WRD #SBET #MGNX #LUNR #HIVE #SHCO #ONDS #ARRY #CIFR #DNN #GDRX #VTAK #FFAI #PPCB - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0
🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#DKNG, #GDRX, #AVGO, #JD, #IQ

#OptionFlow #OptionsTrading #Trading

0 0 0 0
🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MO, #GDRX, #IQ, #FLO, #APPS

#OptionFlow #OptionsTrading #Trading

0 0 0 0
🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #MO 3.5x
2. #GDRX 3.1x
3. #FSLR 2.8x
4. #IQ 2.6x
5. #FLO 2.0x

#OptionFlow #OptionsTrading #Trading

0 0 0 0
Preview
$499 Monthly Ozempic Access: GoodRx and Novo Nordisk Launch Groundbreaking Affordability Program GoodRx partners with Novo Nordisk to offer Ozempic and Wegovy at $499/month for self-paying patients. Program reaches 70,000+ pharmacies amid 22% surge in GLP-1 medication interest.

#GDRX GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

www.stocktitan.net/news/GDRX/good-rx-announ...

0 0 0 0
GoodRx Reports Second Quarter 2025 Results GoodRx (NASDAQ:GDRX), the leading U.S. medication savings platform, reported Q2 2025 results with revenue of $203.1 million, up 1% year-over-year. The company achieved net income of $12.8 million with a 6.3% margin and Adjusted EBITDA of $69.4 million with a 34.2% margin.While Pharma manufacturer solutions revenue grew significantly by 32% to $35.0 million, prescription transactions revenue declined 3% to $143.1 million, and subscription revenue fell 7% to $20.5 million. The company faces headwinds from Rite Aid's bankruptcy and volume reduction in an integrated savings program, expecting a $35-40 million revenue impact in 2025. During Q2, GoodRx repurchased 10.2 million shares for $46.4 million.For FY2025, management expects revenue growth over 2024's $792.3 million and Adjusted EBITDA between $265-275 million, representing 2-6% growth.

#GDRX GoodRx Reports Second Quarter 2025 Results

www.stocktitan.net/news/GDRX/good-rx-report...

0 0 0 0
Preview
GoodRx Disrupts ED Market With $18 Monthly All-in-One Treatment Service, No Doctor Visit Required New subscription combines virtual consultations, FDA-approved medication, and discreet delivery. Targets 86% of untreated ED market. See complete pricing details.

#GDRX GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers

www.stocktitan.net/news/GDRX/good-rx-launch...

0 0 0 0
Preview
GoodRx Disrupts Pharmacy Market with New Cost-Plus Pricing Model for Independent Stores GoodRx introduces Community Link, a revolutionary cost-plus pricing program designed to transform independent pharmacy economics. See how it works.

#GDRX GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing

www.stocktitan.net/news/GDRX/good-rx-launch...

0 0 0 0
Preview
GoodRx Launches Free Developer Tool That Slashes Testing Time and Infrastructure Costs Discover Lifecycle, GoodRx's new open-source tool for automated testing environments. Learn how it reduces deployment friction and cuts infrastructure costs. Get started now.

#GDRX GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

www.stocktitan.net/news/GDRX/good-rx-open-s...

1 0 0 0
Preview
GoodRx Disrupts Pharmacy Pricing: New Platform Gives Independent Pharmacies Direct Control Over Margins New GoodRx Community Link enables cost-plus pricing for independent pharmacies. Platform promises better margins and pricing control. See how it transforms pharmacy economics.

#GDRX GoodRx to Launch Direct Contracting for Independent Community Pharmacies

www.stocktitan.net/news/GDRX/good-rx-to-lau...

0 0 0 0
SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Wed May 7th - #WRD #SYTA #OKYO #KAVL #SNCR #MYGN #LFVN #HAIN #GDRX #YAAS #ARIS #BGS #EPC #GFR #MAGN #RVLV #VSTS #ALZN #BNR #CEVA - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0
Preview
GoodRx Reports First Quarter 2025 Results GoodRx (NASDAQ: GDRX) reported its Q1 2025 financial results with revenue of $203.0 million, up 3% year-over-year. The company posted a net income of $11.1 million with a 5.4% margin, compared to a net loss in the previous year. Key metrics include Adjusted EBITDA of $69.8 million with a 34.4% margin. Prescription transactions revenue grew 2% to $148.9 million, while pharma manufacturer solutions revenue increased 17% to $28.6 million. The company maintained its full-year 2025 revenue guidance of $810-840 million and raised Adjusted EBITDA expectations to $273-287 million. During Q1, GoodRx repurchased 23.3 million shares for $100.9 million and ended the quarter with $301.0 million in cash and $498.8 million in debt.

#GDRX GoodRx Reports First Quarter 2025 Results

www.stocktitan.net/news/GDRX/good-rx-report...

0 0 0 0
SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Tue May 6th - #TRUE #SEAT #REPL #PRAA #OFIX #GDRX #CAPR #FWRG #ANTX #SQNS #PACK #HZAC #ETD #BRCC - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0